Cita APA (7a ed.)

Klavdianou, K., Melissaropoulos, K., Filippopoulou, A., & Daoussis, D. (2021). Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A.

Cita Chicago Style (17a ed.)

Klavdianou, Kalliopi, Konstantinos Melissaropoulos, Alexandra Filippopoulou, y Dimitrios Daoussis. Should We Be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A, 2021.

Cita MLA (8a ed.)

Klavdianou, Kalliopi, et al. Should We Be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A, 2021.

Precaución: Estas citas no son 100% exactas.